Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Zengjun Liu

4PUBLICATIONS

28CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAdolescent health

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 24, 2026

Human Pancreatic Cancer Organoids.

|Oct 23, 2025

First-line Anlotinib plus Anthracyclines and Ifosfamide Followed by Anlotinib Maintenance in Advanced Soft-Tissue Sarcoma: A Phase II Single-Arm Trial.

Jun-Kai Zhao, Zeng-Jun Liu, Rui Wang

|Aug 28, 2025

Sintilimab plus Anlotinib in Patients with Pretreated Locally Advanced or Metastatic Sarcoma: A Prospective, Single-Arm, Phase II Clinical Trial.

Heng Fu, Zengjun Liu, Mengyao Liu

|Apr 24, 2023

Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.

Zengjun Liu, Yang Xiao, Jing Xu

Pageof 1

Frequent Collaborators

3 joint publications

Dongyuan Zhu

2 joint publications

Heng Fu

2 joint publications

Mengyao Liu

2 joint publications

Jing Xu

2 joint publications

Xin Xu

2 joint publications

Jianbo Zhang

2 joint publications

Hongtu Yuan

2 joint publications

Ting Hao

1 joint publications

Hua Xiong

1 joint publications

Rui Wang

Frequent Collaborators

3 joint publications

Dongyuan Zhu

2 joint publications

Heng Fu

2 joint publications

Mengyao Liu

2 joint publications

Jing Xu

Top Related Videos

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on : May 26, 2023

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on : Apr 11, 2018

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on : Jan 31, 2025

See more related videos

Top Related Videos

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on : May 26, 2023

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on : Apr 11, 2018

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on : Jan 31, 2025

See more related videos